Skip to main content
Caplight Logo









NanoMosaic

NanoMosaic

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://nanomosaicllc.com/

Last Round

Series A

Dec 6, 2021

Total Funding Raised

$40.75M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NanoMosaic is a biotechnology company that develops advanced analytical platforms for multiomic biomarker detection, gene therapy manufacturing, and molecular profiling.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

adeno-associated virusAAVnanoneedle technologygene therapy analyticsbioprocess analyticsquality controlanalytical platformbiotech instrumentationviral vector characterizationadvanced manufacturing technologyAMTlab automationbiopharma QCprocess analytical technologyPAT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoMosaic Comparables

Compare NanoMosaic with similar companies based on industry and business-model similarity.

NanoMosaic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abselion
84%
Refeyn
80%
ProteoWise
78%

NanoMosaic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 6, 2021
SeedApr 2, 2020

Key People

Founding team and executive leadership

Qimin Quan

Chief Scientific Officer Co-Founder

Founding Team

Philippe M.

Chief Executive Officer

Executive Team

NanoMosaic Investors

Notable investors and investment history

NanoMosaic investors
InvestorRounds
RA Capital ManagementSeries A
Time BioVenturesSeries A
Tiger Gene L.L.C.Series A, Seed
Insight PartnersSeries A
Pura Vida InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 497% MoM, reaching 3.8K.

  • May 11, 2026

    Will attend the American Society of Gene & Cell Therapy Annual Meeting in Boston.

NanoMosaic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NanoMosaic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NanoMosaic's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range14
Year Founded2017
Last FundingDec 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?